Bone News and Research

RSS

Treatments targeting the gut microbiome can protect space travelers from adverse health problems

Space travelers who spend long periods of time in space can experience health problems, such as adverse effects on metabolism, and immunity.

9 Sep 2020

Researchers determine how prokaryotic and single-celled origins contribute to human evolution

Immune responses are produced by a complex, hierarchical organization of the immune system, tissues, organs, and components.

7 Sep 2020

Exploring evolutionary development of mammalian middle ear based on Cretaceous Jehol fossils

A joint research team led by Dr. MAO Fangyuan from the Institute of Vertebrate Paleontology and Paleoanthropology (IVPP) of the Chinese Academy of Sciences and Prof. MENG Jin from the American Museum of Natural History has reported a new multituberculate mammal, Sinobaatar pani, with well-preserved middle ear bone

28 Aug 2020

New syringe technology for subcutaneous injection of viscous formulations

MIT researchers have developed a simple, low-cost technology to administer powerful drug formulations that are too viscous to be injected using conventional medical syringes.

25 Aug 2020

Greater gut microbial diversity in kidney cancer patients linked to better treatment outcomes

Physicians at City of Hope, working in collaboration with scientists at Translational Genomics Research Institute (TGen), have found that greater gut microbial diversity in patients with metastatic kidney cancer is associated with better treatment outcomes on Food and Drug Administration-approved immunotherapy regimens.

20 Aug 2020

LJI scientists tracked down rare stem cells that generate neutrophils in humans

Neutrophils are the warriors of the immune system. They are always ready to spring to action to help heal injuries or fight off disease. Unless, that is, something goes wrong in their developmental process.

19 Aug 2020

RNA-based therapeutic approach could be used to cure hereditary diseases

Short RNA molecules can be used as medication. Their effectiveness is based on the genetic information they carry: therapeutic RNA can bind to the body's own RNA and thus influence how it functions.

19 Aug 2020

Novel gene editing approach removes latent herpes simplex virus 1

Infectious disease researchers at Fred Hutchinson Cancer Research Center have used a gene editing approach to remove latent herpes simplex virus 1, or HSV-1, also known as oral herpes.

19 Aug 2020

Study reveals why immunity boost from seasonal flu vaccines is not long lasting

A study from Emory Vaccine Center provides insights into why the boost in immunity from seasonal flu vaccination lasts for months but not years, unlike some childhood vaccinations.

14 Aug 2020

A genetic link discovered to predict treatment response for patients with rare, aggressive cancer

A Singapore team led by clinician-scientists and researchers from the National Cancer Centre Singapore (NCCS) discovered a genetic link to better predict treatment response for relapsed/refractory patients with natural- killer T-cell lymphoma (NKTCL), a highly aggressive form of blood cancer.

13 Aug 2020

Oxytocin can help control and prevent osteoporosis

Oxytocin, produced by the hypothalamus and sometimes known as the "love hormone" for its involvement in pair bonding and orgasm, can be a strong ally in the control and prevention of osteoporosis, according to a study by scientists at São Paulo State University in Brazil.

11 Aug 2020

Epigenetics key to daily production of 10 billion blood cells without mistakes

Just one in 2,000 bone marrow cells are hematopoietic stem cells (HSC), but these are the source of the ten billion blood cells humans make every day.

6 Aug 2020

Deep Learning On Cell Signaling Networks Establishes AI For Single-Cell Biology

Computer systems that emulate key aspects of human problem solving are commonly referred to as AI. This field has seen massive progress over the last years.

6 Aug 2020

Biologists identify a molecular mechanism that underlies phenotypic plasticity

Evolutionary and developmental biologist Craig Albertson and colleagues at the University of Massachusetts Amherst report that they have identified a molecular mechanism that allows an organism to change the way it looks depending on the environment it is exposed to, a process known as phenotypic plasticity.

29 Jul 2020

Clinical trial shows CAR-T cell therapy can be used for treating Hodgkin lymphoma

CAR-T cell therapy, which attacks cancer cells using a person's reprogrammed immune cells, has been used to treat Hodgkin lymphoma with remarkable success for the first time, according to the results of an early phase clinical trial led by researchers at UNC Lineberger Comprehensive Cancer Center and Baylor College of Medicine in Houston.

24 Jul 2020

Evaluating the impact of sugary and acidic drinks on tooth enamel

Using atomic force microscopy, researchers have quantitatively assessed the effect of sugary and acidic drinks on human tooth enamel at the nanoscale level.

23 Jul 2020

Reactivating divergent signaling pathways to enhance cancer treatment

In order for cancer to form in the human body, normal cells must acquire multiple mutations before they develop toward the disease. It was previously believed that these mutations acted in concert in the progression of cancer.

23 Jul 2020

Fusion protein found to effective at treating pulmonary arterial hypertension

Pulmonary arterial hypertension (PAH) is an insidious disease. Symptoms may begin slowly, and even before they appear, extensive damage has caused the obstruction of small arteries leading to increased blood pressure in the lungs.

22 Jul 2020

Novel genetic measure could improve screening for osteoporosis

An international team of scientists has developed a novel genetic measure that could dramatically improve how doctors assess the risk of sustaining a fracture due to osteoporosis or fragility.

22 Jul 2020

Josep Carreras Institute creates spin-off to develop CAR-T based therapies for leukemia

The Josep Carreras Leukaemia Research Institute, a public centre pertaining to the Generalitat de Catalunya's (Government of Catalonia) CERCA network, has created the OneChain Immunotherapeutics spin-off, the aim of which is to develop new immuno-oncological therapeutic tools with various preclinical candidates, based on CAR-T technology for different tumors, such as cortical T-cell acute lymphoblastic leukemia (coT-ALL), a rare subtype of leukemia that mainly affects children, and which has a poor prognosis.

21 Jul 2020

Bone News and Research

Treatments targeting the gut microbiome can protect space travelers from adverse health problems

Researchers determine how prokaryotic and single-celled origins contribute to human evolution

Exploring evolutionary development of mammalian middle ear based on Cretaceous Jehol fossils

New syringe technology for subcutaneous injection of viscous formulations

Greater gut microbial diversity in kidney cancer patients linked to better treatment outcomes

LJI scientists tracked down rare stem cells that generate neutrophils in humans

RNA-based therapeutic approach could be used to cure hereditary diseases

Novel gene editing approach removes latent herpes simplex virus 1

Study reveals why immunity boost from seasonal flu vaccines is not long lasting

A genetic link discovered to predict treatment response for patients with rare, aggressive cancer

Oxytocin can help control and prevent osteoporosis

Epigenetics key to daily production of 10 billion blood cells without mistakes

Deep Learning On Cell Signaling Networks Establishes AI For Single-Cell Biology

Biologists identify a molecular mechanism that underlies phenotypic plasticity

Clinical trial shows CAR-T cell therapy can be used for treating Hodgkin lymphoma

Evaluating the impact of sugary and acidic drinks on tooth enamel

Reactivating divergent signaling pathways to enhance cancer treatment

Fusion protein found to effective at treating pulmonary arterial hypertension

Novel genetic measure could improve screening for osteoporosis

Josep Carreras Institute creates spin-off to develop CAR-T based therapies for leukemia

Driving Support for Pharmaceutical Testing Through Continuous Innovation

From Memory to Metaplasticity: Unraveling the Brain's Secrets

Revolutionizing Mass Spectrometry: A Deep Dive into Plasmion’s SICRIT® Technology

Latest in Genomics